$2.45
+0.13 (+5.60%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,490.6% upside
Low Target
$29.17
Average Target
$38.97
High Target
$44.78
Current Price
$2.45
Current
$2.45
$2.45
Target
$38.97
$38.97
$29.17
$38.97 avg
$44.78
Scenario Analysis
Bear Case
$29.17
1,090.6%
Low target
Base Case
$38.97
+1,490.6%
Avg target
Bull Case
$44.78
+1,727.8%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$7.80
-68.6% from high
52-Week Low
$1.31
+87.0% from low
Target vs 52W High
$38.97
+399.6% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
EPS Est: $-0.28
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |